Can B (OTC:CANB) Stock, Quote.Headers.trade-ideas

Can B Corp is engaged in the business of promoting health and wellness through its development, manufacture and sale of products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. The company focuses on developing a line of proprietary products in the Hemp Industry.

Cannabis

Earnings

News

Markets

CANB

Despite showing a decrease of 26% Year-Over-Year for Q3, the company highlighted the fact that it is its Tenth Consecutive Positive Quarter

Canadian CanadaBis Reports C$3.97M Net Revenue In Q3 2024, 26% Decline YoY

Penny Stocks

Can B Corp. (OTCQB: CANB) released its financial results for the twelve months ended December 31, 2022, revealing revenue increased 45% to $6.7 million, compared with $4.6 million in 2021.

Financial Highlights for 2022

Can B Corp. FY22 Revenue Grows 45% To $6.7M, Here Are The Details

Can B Corp. (OTCQB: CANB) released financial results for the third quarter and nine months ended September 30, 2022, revealing revenue of $2.9 million, an increase of $1.0 million, or 51%, compared with $1.9 million for the three months ended September 30, 2

Comments

Can B

Can B (OTC:CANB) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell